Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
psychoactive compound |
gptkbp:CASNumber |
83729-01-5
|
gptkbp:category |
psychedelic
natural product Hallucinogen diterpene esters acetate esters furans terpenoid kappa-opioid receptor agonist plant metabolite lactones neoclerodane diterpene |
gptkbp:color |
white
|
gptkbp:crystalForm |
crystalline solid
|
gptkbp:discoveredBy |
Alfredo Ortega
|
gptkbp:discoveredIn |
1982
|
gptkbp:eliminationHalfLife |
short (minutes)
|
gptkbp:foundIn |
gptkb:Salvia_divinorum
|
gptkbp:hasMolecularFormula |
C23H28O8
|
gptkbp:hasSMILES |
CC1(C2C(CC3=C(C2CCC1OC(=O)C)C(=O)OC3)C4=COC=C4)C(=O)OC
|
https://www.w3.org/2000/01/rdf-schema#label |
salvinorin A
|
gptkbp:IUPACName |
(2S,4aR,6aR,7R,9S,10aR,10bS)-9-(furan-3-yl)-2,6a,10b-trimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10,10a,10b-decahydro-2H-benzo[f]isochromene-7-carboxylate acetate
|
gptkbp:legalStatus |
varies by country
|
gptkbp:metabolism |
liver
|
gptkbp:molecularWeight |
432.46 g/mol
|
gptkbp:naturalOccurrence |
gptkb:Salvia_divinorum
|
gptkbp:psychoactive |
dissociation
hallucinations altered perception |
gptkbp:PubChem_CID |
123940
CHEBI:145635 CHEMBL254963 DB12753 |
gptkbp:relatedTo |
salvinorin B
salvinorin C |
gptkbp:routeOfAdministration |
inhalation
sublingual oral (ineffective) |
gptkbp:solubility |
insoluble in water
soluble in ethanol soluble in acetone soluble in chloroform |
gptkbp:status |
Schedule I (USA, some states)
|
gptkbp:target |
gptkb:kappa-opioid_receptor
|
gptkbp:toxicity |
low (in animal studies)
|
gptkbp:UNII |
6T3D8C1DZE
|
gptkbp:bfsParent |
gptkb:Salvia
|
gptkbp:bfsLayer |
6
|